Molecular Docking Study Characterization of Rare Flavonoids at the Nac-Binding Site of the First Bromodomain of BRD4 (BRD4 BD1)
Journal of Cancer Research · 2015
DOI: 10.1155/2015/762716 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cancer Research, 2015. Verfasst von Karthik Dhananjayan. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
ε -N-Acetylation of lysine residues (Kac) is one of the most frequently occurring posttranslational modifications (PTMs) which control gene transcription and a vast array of diverse cellular functions. Bromodomains are epigenetic regulators involved in posttranslational modification. In silico docking studies were carried out to evaluate the binding potential of selected rare flavonoids on to Nac binding site of BD1 domain of BRD4 BET family proteins. Rare flavonoids like 3-O-acetylpinobanksin, naringenin triacetate, and kaempferol tetraacetate were found to occupy the WPF shelf and at the same time they exhibited a better binding affinity with multiple crystal structures of first bromodomain BRD4 (BRD4 BD1) when compared with the known inhibitors.
Zitieren
APA
Dhananjayan, K. (2015). Molecular Docking Study Characterization of Rare Flavonoids at the Nac-Binding Site of the First Bromodomain of BRD4 (BRD4 BD1). Journal of Cancer Research. https://doi.org/10.1155/2015/762716
Vancouver
Dhananjayan K. Molecular Docking Study Characterization of Rare Flavonoids at the Nac-Binding Site of the First Bromodomain of BRD4 (BRD4 BD1). Journal of Cancer Research. 2015. doi:10.1155/2015/762716
BibTeX
@article{Dhananjayan2015,
author = {Dhananjayan, Karthik},
title = {Molecular Docking Study Characterization of Rare Flavonoids at the Nac-Binding Site of the First Bromodomain of BRD4 (BRD4 BD1)},
journal = {Journal of Cancer Research},
year = {2015},
doi = {10.1155/2015/762716}
}
EUVIMED